Chronic beryllium disease: a model interaction between innate and acquired immunity (Q23920162)

2 August 2017

1 reference

title

Chronic beryllium disease: a model interaction between innate and acquired immunity (English)

2 references

12 July 2017

National Institute for Occupational Safety and Health

2 August 2017

0 references

2 references

19 July 2017

29 March 2020

1 reference

29 March 2020

1 reference

29 March 2020

1 reference

29 March 2020

1 reference

29 March 2020

4

Lee S Newman

1 reference

2 August 2017

Richard T Sawyer

1

1 reference

2 August 2017

Lisa A Maier

series ordinal

2

1 reference

2 August 2017

Lori A Kittle

series ordinal

3

1 reference

2 August 2017

language of work or name

1 reference

February 2002

0 references

1 February 2002

1 reference

International Immunopharmacology

2 August 2017

1 reference

2 August 2017

2

1 reference

2 August 2017

2-3

1 reference

2 August 2017

249-261

1 reference

2 August 2017

performing organization

National Jewish Health

object named as

National Jewish Medical and Research Center, Department of Medicine, Denver, Colorado

1 reference

NIOSHTIC-2

on focus list of Wikimedia project

2 February 2024

Wikimedia–NIOSH collaboration

0 references

funding scheme

cooperative agreement

1 reference

25 September 2023

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Significance of the blood beryllium lymphocyte proliferation test

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Early pulmonary physiologic abnormalities in beryllium disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Observer variation and relationship of computed tomography to severity of beryllium disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Compartmentalized immune response reflects clinical severity of beryllium disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Beryllium disease. The relation of pulmonary pathology to clinical course and prognosis based on a study of 130 cases from the U.S. beryllium case registry

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

The pulmonary toxicity of beryllium

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Chronic beryllium disease--from the workplace to cellular immunology, molecular immunogenetics, and back

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Chronic beryllium disease in a dental laboratory technician

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Effect of dental base metal alloys on IgE levels and some blood parameters

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Comparison of in vivo and in vitro measures of beryllium sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

New pathogenetic insights into the sarcoid granuloma

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Chronic beryllium disease: diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Immunology, genetics, and epidemiology of beryllium disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

The carcinogenicity of metals in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Review of occupational lung carcinogens

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Beryllium copper alloy (2%) causes chronic beryllium disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Nonoccupational beryllium disease masquerading as sarcoidosis: identification by blood lymphocyte proliferative response to beryllium

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Selective intracellular beryllium localization in rat tissue by mass-resolved ion microprobe imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Ferritin and in vivo beryllium toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Binding of beryllium to nuclear acidic proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Uptake, distribution and binding of beryllium to organelles of the rat liver cell

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Effects of beryllium on deoxyribonucleic acid-synthesizing enzymes in regenerating rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Beryllium toxicity. The selective inhibition of casein kinase 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Metal-induced infidelity during DNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Acute pulmonary toxicity of beryllium sulfate inhalation in rats and mice: cell kinetics and histopathology

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Bronchoalveolar lavage in rats and mice following beryllium sulfate inhalation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Immunologic specificity of lymphocyte cell lines from dogs exposed to beryllium oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Monitoring of serum KL-6 antigen in a patient with radiation pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Toxicological effects of beryllium on platelets and vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

[The changes of complement activities in sera of mice after subcutaneous administration of beryllium chloride]

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Beryllium-stimulated in vitro migration of peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Expansions of T-cell subsets expressing particular T-cell receptor variable regions in chronic beryllium disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Beryllium, an adjuvant that promotes gamma interferon production

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-alpha and interleukin-6 but not interleukin-1 beta

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

IL-4 fails to regulate in vitro beryllium-induced cytokines in berylliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Tumor necrosis factor alpha gene expression in human monocytic THP-1 cells exposed to beryllium

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Regulation of cytokine gene expression by adjuvants in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Exposure of cultured murine peritoneal macrophages to low concentrations of beryllium induces increases in intracellular calcium concentrations and stimulates DNA synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Beryllium-stimulated production of tumor necrosis factor-alpha by a mouse hybrid macrophage cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Beryllium-stimulation does not activate transcription factors in a mouse hybrid macrophage cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Beryllium-stimulated apoptosis in macrophage cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Human CD14 mediates recognition and phagocytosis of apoptotic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

p38 mitogen-activated protein kinase-dependent and -independent intracellular signal transduction pathways leading to apoptosis in human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Monocyte CD14: a multifunctional receptor engaged in apoptosis from both sides.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Phagocyte recognition of cells undergoing apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Evaluations of metabolic activities as biocompatibility tools: a study of individual ions' effects on fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Chronic beryllium disease in identical twins

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Marked tachypnea in siblings with chronic beryllium disease due to copper-beryllium alloy

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

HLA-DPB1 glutamate 69: a genetic marker of beryllium disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Interaction of genetic and exposure factors in the prevalence of berylliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Serum Angiotensin Converting Enzyme Activity in Chronic Beryllium Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Angiotensin-1 converting enzyme polymorphisms in chronic beryllium disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

High beryllium-stimulated TNF-alpha is associated with the -308 TNF-alpha promoter polymorphism and with clinical severity in chronic beryllium disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

Increased glutathione and glutathione peroxidase in lungs of individuals with chronic beryllium disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900177-1

7 January 2021

10.1016/S1567-5769(01)00177-1

Identifiers

DOI

1 reference

2 August 2017

0 references

1 reference